The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pharmacokinetic/pharmacodynamic (PK/PD) profile of AG-120 in patients with IDH1-mutant cholangiocarcinoma from a phase 1 study of advanced solid tumors.
 
Bin Fan
Employment - Agios
Stock and Other Ownership Interests - Agios
 
Lipika Goyal
Honoraria - Ribon Therapeutics
Research Funding - Dicerna; Exelixis; Leap Therapeutics; Taiho Pharmaceutical
 
Maeve Aine Lowery
Consulting or Advisory Role - Agios; Celgene
 
Shuchi Sumant Pandya
Employment - Acceleron Pharma; Agios
Stock and Other Ownership Interests - Acceleron Pharma; Agios
Research Funding - Acceleron Pharma; Agios
Travel, Accommodations, Expenses - Acceleron Pharma; Agios
 
Erika Manyak
Employment - Agios
Stock and Other Ownership Interests - Agios
Research Funding - Agios
 
Kha Le
Employment - Agios
Stock and Other Ownership Interests - Agios
Patents, Royalties, Other Intellectual Property - Millennium
 
Liewen Jiang
Employment - Agios
Stock and Other Ownership Interests - Alexion Pharmaceuticals
 
Julia Auer
Employment - Agios
Stock and Other Ownership Interests - Agios
 
David Dai
Employment - Agios
Stock and Other Ownership Interests - Agios; Biogen; Bristol-Myers Squibb; Celldex; Cempra